Germany Becomes Latest European Country to Suspend Use of AstraZeneca's Covid-19 Vaccine -- 2nd Update
15 März 2021 - 5:47PM
Dow Jones News
By Bojan Pancevski and Jenny Strasburg
BERLIN -- Germany, France and Italy joined a group of smaller
European countries that have temporarily stopped administering
Covid-19 vaccines made by AstraZeneca PLC, saying the move was
precautionary amid a small number of cases of blood clotting
reported on the continent.
Denmark last week said it had paused AstraZeneca shots for two
weeks following reports of blood clotting, and several other
European countries quickly followed suit, saying they were doing so
out of an abundance of caution. Norway, Ireland and the Netherlands
are among countries that have paused vaccinating with AstraZeneca's
shot.
Health regulators in the U.K. and Europe, along with AstraZeneca
and its vaccine development partners at the University of Oxford,
say there is no known connection between severe clotting and the
shot. AstraZeneca has said the number of cases of blood clotting
among the roughly 17 million people in the European Union and U.K.
who have received the shot is lower than for the general
population.
Europe's medicines regulator said last week it was looking into
around 30 reported cases of severe clotting, out of around five
million people who have received the shot in the bloc. Last week,
the regulator, the European Medicines Agency, said the "vaccine's
benefits currently still outweigh risks" and has continued
recommending its use. The agency said most side effects are mild or
moderate. Clinical trials didn't raise flags about blood clotting
as a risk.
Write to Bojan Pancevski at bojan.pancevski@wsj.com and Jenny
Strasburg at jenny.strasburg@wsj.com
(END) Dow Jones Newswires
March 15, 2021 12:32 ET (16:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024